Zuanic favors Aurora and Aphria, which he rates as overweight, the equivalent of buy. Vireo was set up five years ago with a team led by doctors, scientists and engineers as a medical cannabis company that has developed into a multistate operator. U.S.-listed shares were not active premarket, but have fallen 10% in the year to date, while the Cannabis ETF has fallen 5% and the S&P 500 is flat. No Ideas published for this Pot ETF yet so I figured I'd paint one on here. Employees:---News. Sanghamitra Saha - ZACKS - Mon Jun 1, 12:00PM CDT Sanghamitra Saha - ZACKS - Tue May 26, 12:00PM CDT Sanghamitra Saha - ZACKS - Thu May 7, 12:00PM CDT Sanghamitra Saha - ZACKS - Mon Mar 30, 12:00PM CDT Sanghamitra Saha - ZACKS - Fri Mar 27, 12:00PM CDT Sanghamitra Saha - ZACKS - Wed Feb 19, 12:00PM CST Sanghamitra Saha - ZACKS - Mon Jan 20, 7:00AM CST The Cannabis ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Innovation Labs Cannabis Index. The U.S.-listed stock has more than doubled (up 107.7%) over the past three months through Tuesday, while the Cannabis ETF has climbed 60.2% and the S&P 500 has rallied 23.6%.Aurora Cannabis Inc. said Tuesday that co-Founder Steve Dobler will retire from his roles as president and board member, effective June 30.
Revenue net of excise taxes fell to C$18.0 million from C$24.8 million. "Newly launched products such as hash and oil extract drops also contributed to overall adult-use sales growth." THCX, 240. altinAdam. "As the market share leader, anchored in science, sponsoring ValidCare's study made strategic sense for us," Chief Executive Deanie Elsner said in a statement. What does a stratospheric rally for gold mean for the stock market? Proceeds of both deals will be used for general corporate purposes and working capital. Hexo booked impairment charges of C$138.3 million on its Niagara facility and intangible assets acquired from Newstrike Brands Ltd. "Canopy Growth sports the resources to deliver on its ambitions of leading growth in the global cannabis category, but the resources have yet to produce tangible evidence of on an enduring right to win in the developing category," Carter wrote in a note to clients. Canopy shares tumbled after the company's March quarter sales fell short of estimates and the company pulled guidance for reaching positive EBITDA. Vireo shares were not active premarket, but have fallen 48% in the year to date. Today's Latest Price: $10.64 USD. The program's agents are AltaCorp Capital Inc. in Canada and Oppenheimer & Co. Inc. in the U.S.

Touch device users, explore by touch or with swipe gestures.The Cannabis ETF (THCX) Declares Dividend DistributionSundial Added to the NYSE-Listed "The Cannabis ETF"var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /^([^@\s]+)@((?:[-a-z0-9]+\. Is it right time to buy marijuana ETFs? The two companies had the industry's higher B2B recreational sales in the March quarter, he wrote. U.S.-listed hares were down 1.8% premarket and have fallen 52% in the year to date, while the Cannabis ETF has and the S&p 500 has fallen 24% and the S&P 500 has fallen 7%.
60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). The FactSet consensus was for a loss per share of 4 cents and revenue of C$22.4 million. The Summary Quoteboard displays snapshot quote data. Quick Links "We believe ongoing cash needs, potential equity dilution, and risk around debt covenants remain as impediments to a more constructive approach with the shares enjoying a still robust valuation (C$2.5 billion enterprise value)," the analysts wrote. "This research will provide important clinical data to guide our entire industry while also showing the FDA we've heard their requests and are answering their questions with precise data." Nasdaq Initiatives